UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in shares of Ameren Co. (NYSE:AEE - Free Report) by 3.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 969,024 shares of the utilities provider's stock after selling 39,267 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.36% of Ameren worth $84,751,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in the stock. FMR LLC raised its holdings in shares of Ameren by 59.8% in the 3rd quarter. FMR LLC now owns 2,631,580 shares of the utilities provider's stock worth $230,158,000 after acquiring an additional 984,879 shares during the last quarter. Millennium Management LLC increased its position in shares of Ameren by 106.1% during the 2nd quarter. Millennium Management LLC now owns 2,498,158 shares of the utilities provider's stock valued at $177,644,000 after purchasing an additional 1,286,162 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Ameren by 6.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,954,962 shares of the utilities provider's stock worth $139,017,000 after purchasing an additional 123,427 shares during the period. Maple Brown Abbott Ltd boosted its holdings in shares of Ameren by 2.3% in the 2nd quarter. Maple Brown Abbott Ltd now owns 1,753,270 shares of the utilities provider's stock worth $124,675,000 after buying an additional 38,750 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Ameren by 1.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,653,542 shares of the utilities provider's stock valued at $144,619,000 after buying an additional 30,511 shares during the period. 79.09% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
AEE has been the topic of a number of research reports. BMO Capital Markets lifted their price target on shares of Ameren from $84.00 to $87.00 and gave the stock an "outperform" rating in a report on Tuesday, August 6th. Bank of America increased their price objective on Ameren from $86.00 to $87.00 and gave the stock a "neutral" rating in a research report on Thursday, August 29th. Barclays boosted their target price on Ameren from $77.00 to $88.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Mizuho upgraded Ameren from a "neutral" rating to an "outperform" rating and lifted their price target for the company from $82.00 to $89.00 in a research report on Monday, September 16th. Finally, Wells Fargo & Company upped their price objective on shares of Ameren from $91.00 to $96.00 and gave the stock an "overweight" rating in a research report on Friday, September 20th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $87.78.
View Our Latest Stock Analysis on AEE
Insider Buying and Selling
In other news, CFO Michael L. Moehn sold 6,500 shares of the business's stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $92.15, for a total transaction of $598,975.00. Following the completion of the sale, the chief financial officer now directly owns 205,171 shares of the company's stock, valued at approximately $18,906,507.65. The trade was a 3.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.36% of the stock is currently owned by company insiders.
Ameren Price Performance
Shares of NYSE:AEE traded down $1.08 during mid-day trading on Tuesday, reaching $91.80. The stock had a trading volume of 920,218 shares, compared to its average volume of 1,577,346. The company has a market cap of $24.50 billion, a P/E ratio of 21.66, a price-to-earnings-growth ratio of 3.06 and a beta of 0.48. The business's 50 day moving average price is $89.13 and its 200 day moving average price is $81.16. The company has a current ratio of 0.63, a quick ratio of 0.41 and a debt-to-equity ratio of 1.37. Ameren Co. has a 1 year low of $67.03 and a 1 year high of $95.69.
Ameren Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Wednesday, December 11th will be issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 2.92%. The ex-dividend date is Wednesday, December 11th. Ameren's payout ratio is 63.06%.
Ameren Company Profile
(
Free Report)
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.
Further Reading
Before you consider Ameren, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ameren wasn't on the list.
While Ameren currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.